Healthcare & Life Sciences
Ability
Canadaability.bio/
Ability is a Healthcare & Life Sciences startup based in Canada, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Ability
Based in Canada, Ability is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ability develops fully-human precision biotherapeutic antibodies using its proprietary AI-driven discovery platform AbiLeap™ to target specific immune cell subpopulations for autoimmune, inflammatory diseases, and cancer therapies.
Explore Ability's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.